Loading publications…
The last 5 uploaded publications
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Luc Wasungu, Susan Veldhof, Lei Peng, Peter Stæhr, Maik J. Grundeken, Yuki Ishibashi, Héctor M. García‐García, Yoshinobu Onuma (2014). A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. The Lancet, 385(9962), pp. 43-54, DOI: 10.1016/s0140-6736(14)61455-0.
Article146 days agoA Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions
Philippe Généreux, Indulis Kumsārs, Maciej Lesiak, Annapoorna Kini, Géza Fontos, Ton Slagboom, Imre Ungi, D. Christopher Metzger, Joanna J. Wykrzykowska, Pieter R. Stella, Antonio L. Bartorelli, William F. Fearon, Thierry Lefévre, Robert L. Feldman, Laura LaSalle, Dominic P. Francese, Yoshinobu Onuma, Maik J. Grundeken, Héctor M. García‐García, Linda L. Laak, Donald E. Cutlip, Aaron V. Kaplan, Patrick W. Serruys, Martin B. Leon (2015). A Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions. Journal of the American College of Cardiology, 65(6), pp. 533-543, DOI: 10.1016/j.jacc.2014.11.031.
Article146 days agoImpact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial
Mick Renkens, Maik J. Grundeken, Laura S.M. Kerkmeijer, Robin P. Kraak, Deborah N. Kalkman, René J. van der Schaaf, Sjoerd H. Hofma, Karin Arkenbout, Auke Weevers, Karel T. Koch, Yoshinobu Onuma, Patrick W. Serruys, Jan G.P. Tijssen, Robbert J. de Winter, Joanna J. Wykrzykowska, R. Tijssen (2025). Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial. Netherlands Heart Journal, DOI: 10.1007/s12471-025-01937-4.
Article146 days agoComparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up
Shimpei Nakatani, Yohei Sotomi, Yuki Ishibashi, Maik J. Grundeken, Hiroki Tateishi, Erhan Tenekecioğlu, Yaping Zeng, Pannipa Suwannasom, Evelyn Regar, Maria Radu, Lorenz Räber, Hiram G. Bezerra, Marco A. Costa, Peter J. Fitzgerald, Francesco Prati, Ricardo A. Costa, Jouke Dijkstra, Takeshi Kimura, Ken Kozuma, Kengo Tanabe, Takashi Akasaka, Carlo Di Mario, Patrick W. Serruys, Yoshinobu Onuma (2016). Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up. EuroIntervention, 12(12), pp. 1498-1509, DOI: 10.4244/eijy15m10_03.
Article146 days agoFirst generation versus second generation drug‐eluting stents for the treatment of bifurcations: 5‐year follow‐up of the <scp>LEADERS</scp> all‐comers randomized trial
Maik J. Grundeken, Joanna J. Wykrzykowska, Yuki Ishibashi, Scot Garg, Ton de Vries, Héctor M. García‐García, Yoshinobu Onuma, Robbert J. de Winter, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Franz R. Eberli, Roberto Corti, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Bernhard Meier, Peter Jüni, Ashkan Yazdani, Samuel Copt, Stephan Windecker, Patrick W. Serruys (2015). First generation versus second generation drug‐eluting stents for the treatment of bifurcations: 5‐year follow‐up of the <scp>LEADERS</scp> all‐comers randomized trial. Catheterization and Cardiovascular Interventions, 87(7), DOI: 10.1002/ccd.26344.
Article146 days ago